• Home
• About ATSDR
• Press Room
• A-Z Index
• Employment
• Contact Us
• CDC

Trichloroethylene (TCE) Technical Report March 1996

DISCLAIMER

The use of company or product names is for identification only and does not constitute endorsement by the Agency for Toxic Substances and Disease Registry, the Public Health Service, or the U.S. Department of Health and Human Services.

CONTENTS

• EXECUTIVE SUMMARY
  
• SECTION 1--INTRODUCTION
  
• SECTION 2--ENVIRONMENTAL AND REGISTRANT INFORMATION
  
  • Environmental Information
    
  • Data Collection
    
• SECTION 3--COMPARISON OF TCE SUBREGISTRY FOLLOWUP
  DATA AND NATIONAL NORMS
  
  • Rationale for the Comparison
    
  • National Comparison Populations
    
  • Methods of Descriptive Variable Comparisons
    
    • Demographic Characteristics
      
    • Cigarette Smoking
      
  • Methods of Comparing Health Outcomes
    
    • Question Comparability
      
    • Statistical Analyses of Health Data
      
    • Results of Data File Health Outcome Comparisons
      
    • Anemia or Other Blood Disorders
      
    • Arthritis, Rheumatism, or Other Joint Disorders
      
    • Asthma, Emphysema, or Chronic Bronchitis
      
    • Diabetes
      
    • Hearing Impairment
      
    • High Blood Pressure (Hypertension)
      
    • Kidney Disease
      
    • Liver Problems
      
    • Mental Retardation
      
    • Skin Rashes, Eczema, or Other Skin Allergies
      
    • Other Respiratory Allergies or Problems, Such as Hay Fever
      
    • Speech Impairment
      
    • The Effects of a Stroke
      
    • Ulcers, Gallbladder Trouble, or Stomach or
      
    • Intestinal Problems
      
    • Urinary Tract Disorders, Including Prostate Trouble
      
    • Cancers
      
  • SECTION 4--DISCUSSION
    
    • Environmental Data
      
    • Health Outcomes
      
      • Speech Impairment
        
      • Hearing Impairment
        
      • Hypertension
        
      • Effects of Stroke
        
      • Liver Problems
        
      • Anemia or Other Blood Disorders
        
      • Diabetes
        
      • Kidney Disease
        
      • Urinary Tract Disorders
        
      • Skin Rashes, Eczema, or Other Skin Allergies
        
      • Asthma, Emphysema, or Chronic Bronchitis and
        
      • Other Respiratory Problems Such as Hay Fever
        
      • Mental Retardation
        
      • Arthritis, Rheumatism, or Other Joint Disorders
        
      • Cancers
        
      • Summary
        
    • SECTION 5--CONCLUSIONS AND RECOMMENDATIONS
      
      • Conclusions
        
      • Recommendations
        
    • AUTHORS AND ACKNOWLEDGMENTS
      
    • REFERENCES
      

LIST OF TABLES

• Table 2-1.--Summary of environmental data by site.
  
• Table 2-2.--Summary of number of exposed registrants, by race.
  
• Table 2-3.--Number of living participants in the TCE Subregistry
  Baseline and Followup 1 by site.
  
• Table 2-4.--Summary of registrant response at TCE Subregistry
  Followup 1. 11
  
• Table 2-5.--Descriptive data for TCE Subregistry Followup 1
  living registrants (all races)
  
• Table 2-6.--Tobacco use data for TCE Subregistry Followup 1 registrants,
  18 years of age or older (all races).
  
• Table 3-1.--Comparison of the distributions of females in the TCE Subregistry
  Followup 1 and 1990 National Health Interview Survey (NHIS),
  by age group.
  
• Table 3-2.--Comparison of the age distributions in the TCE Subregistry Followup 1 and the 1990 National Health Interview Survey (NHIS) sample.
  
• Table 3-3.--Education level attained for TCE Subregistry Followup 1
  and National Health Interview Survey (NHIS) populations
  (white, 19 years of age or older)
  
• Table 3-4.--Reported rates of cigarette smoking for TCE Subregistry Followup 1,
  National Health Interview Survey (NHIS), and National Household Survey
  on Drug Abuse (NHSDA) populations (white only)
  
• Table 3-5.--Comparison of time frames for health condition questions
  
• Table 3-6.--Comparison of TCE Subregistry Followup 1 and National Health
  Interview Survey (NHIS) health questions
  
• Table 3-7.--Observed (TCE) cases and expected (NHIS) number of expected
  health conditions and risk ratios for TCE Subregistry Followup 1
  
• Table 3-8.--Summary of Poisson regression modeling for
  TCE Subregistry Followup 1.
  
• Table 3-9.--Summary results of TCE Subregistry Followup 1-
  National Health Interview Survey comparison.
  
• Table 3-10.--Summary of TCE Subregistry Followup 1 response rates
  for cancer (time frame is "last 12 months").
  
• Table 4-1.--Summary results of TCE Subregistry and National Health
  

• Home
• Privacy Policy
• Disclaimer
• Accessibility
• e-Government
• FOIA
• Contact Us